GRAMANTIERI, LAURA
GRAMANTIERI, LAURA
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Personale esterno ed autonomi
Circulating CD8 lymphocytes predict response to atezolizumab–bevacizumab in hepatocellular carcinoma
2024 Gramantieri L.; Suzzi F.; Bassi C.; D'Abundo L.; Tovoli F.; Bruccoleri M.; Marseglia M.; Alimenti E.; Fornari F.; Negrini M.; Iavarone M.; Piscaglia F.; Giovannini C.
Multifaceted Aspects of Dysfunctional Myelopoiesis in Cancer and Therapeutic Perspectives with Focus on HCC
2024 Arleo, Andrea; Montagner, Annapaola; Giovannini, Catia; Suzzi, Fabrizia; Piscaglia, Fabio; Gramantieri, Laura
Noncoding RNAs in Hepatocellular Carcinoma: Potential Applications in Combined Therapeutic Strategies and Promising Candidates of Treatment Response
2024 Clara Vianello, Elisa Monti, Ilaria Leoni, Giuseppe Galvani, Catia Giovannini, Fabio Piscaglia, Claudio Stefanelli, Laura Gramantieri, Francesca Fornari
Notch Signaling and PD-1/PD-L1 Interaction in Hepatocellular Carcinoma: Potentialities of Combined Therapies
2024 Montagner, Annapaola; Arleo, Andrea; Suzzi, Fabrizia; D'Assoro, Antonino B.; Piscaglia, Fabio; Gramantieri, Laura; Giovannini, Catia
Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma
2023 Giovannini, Catia; Suzzi, Fabrizia; Tovoli, Francesco; Bruccoleri, Mariangela; Marseglia, Mariarosaria; Alimenti, Eleonora; Fornari, Francesca; Iavarone, Massimo; Piscaglia, Fabio; Gramantieri, Laura
MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma
2023 Bergamini, Christian; Leoni, Ilaria; Rizzardi, Nicola; Melli, Mattia; Galvani, Giuseppe; Coada, Camelia Alexandra; Giovannini, Catia; Monti, Elisa; Liparulo, Irene; Valenti, Francesca; Ferracin, Manuela; Ravaioli, Matteo; Cescon, Matteo; Vasuri, Francesco; Piscaglia, Fabio; Negrini, Massimo; Stefanelli, Claudio; Fato, Romana; Gramantieri, Laura; Fornari, Francesca
Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area
2022 Gramantieri L.; Gnudi F.; Vasuri F.; Mandrioli D.; Fornari F.; Tovoli F.; Suzzi F.; Vornoli A.; D'errico A.; Piscaglia F.; Giovannini C.
Animal Models of Hepatocellular Carcinoma: Current Applications in Clinical Research
2022 Francesca Fornari; Catia Giovannini; Fabio Piscaglia; Laura Gramantieri
MicroRNA as predictive biomarkers of treatment response to tyrosine kinase inhibitors in hepatocellular carcinoma: how much s missing?
2022 Gramantieri Laura; Fornari Francesca
MicroRNAs at the Crossroad between Immunoediting and Oncogenic Drivers in Hepatocellular Carcinoma
2022 Laura Gramantieri, Francesca Fornari, Catia Giovannini, Davide Trere
Pathophysiology roles and translational opportunities of miRNAs in hepatocellular carcinoma
2022 Fornari Francesca; Gramantieri Laura
Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions
2021 Fornari, F; Giovannini, C; Piscaglia, F; Gramantieri, L
Hepatic cancer stem cells: Molecular mechanisms, therapeutic implications, and circulating biomarkers
2021 Gramantieri L.; Giovannini C.; Suzzi F.; Leoni I.; Fornari F.
MicroRNAs as Modulators of Tumor Metabolism, Microenvironment, and Immune Response in Hepatocellular Carcinoma
2021 Gramantieri, L; Giovannini, C; Piscaglia, F; Fornari, F
Notch signaling regulation in HCC: From hepatitis virus to non‐coding rnas
2021 Giovannini C.; Fornari F.; Piscaglia F.; Gramantieri L.
Association of NOS3 and ANGPT2 Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE Study
2020 Casadei-Gardini A; Marisi G; Dadduzio V; Gramantieri L; Faloppi L; Ulivi P; Foschi F G; Tamburini E; Vivaldi C; Rizzato M D; Ielasi L; Canale M; Conti F; Rudnas B; Fornaro L; Silvestris N; Silletta M; Cardellino G G; Lonardi S; Fornari F; Orsi G; Rovesti G; Zagonel V; Cascinu C; Scartozzi M
Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma (Targeted Oncology, (2020), 15, 6, (773-785), 10.1007/s11523-020-00757-3)
2020 Orsi G.; Tovoli F.; Dadduzio V.; Vivaldi C.; Brunetti O.; Ielasi L.; Conti F.; Rovesti G.; Gramantieri L.; Rizzato M.D.; Pecora I.; Argentiero A.; Teglia F.; Lonardi S.; Salani F.; Granito A.; Zagonel V.; Marisi G.; Cabibbo G.; Foschi F.G.; Benevento F.; Cucchetti A.; Piscaglia F.; Cascinu S.; Scartozzi M.; Casadei-Gardini A.
Direct antiviral treatments for hepatitis c virus have off-target effects of oncologic relevance in hepatocellular carcinoma
2020 Giovannini C.; Fornari F.; Indio V.; Trere' D.; Renzulli M.; Vasuri F.; Cescon M.; Ravaioli M.; Perrucci A.; Astolfi A.; Piscaglia F.; Gramantieri L.
MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma
2020 Gramantieri L.; Pollutri D.; Gagliardi M.; Giovannini C.; Quarta S.; Ferracin M.; Casadei-Gardini A.; Callegari E.; De Carolis S.; Marinelli S.; Benevento F.; Vasuri F.; Ravaioli M.; Cescon M.; Piscaglia F.; Negrini M.; Bolondi L.; Fornari F.
Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma
2020 Orsi G.; Tovoli F.; Dadduzio V.; Vivaldi C.; Brunetti O.; Ielasi L.; Conti F.; Rovesti G.; Gramantieri L.; Rizzato M.D.; Pecora I.; Argentiero A.; Teglia F.; Lonardi S.; Salani F.; Granito A.; Zagonel V.; Marisi G.; Cabibbo G.; Foschi F.G.; Benevento F.; Cucchetti A.; Piscaglia F.; Cascinu S.; Scartozzi M.; Casadei-Gardini A.